Merger control is an important part of any competition regime, and effective merger remedies are needed to ensure its efficacy. Remedies are a distinct process within merger control and represent a number of specific challenges that warrant careful consideration, including how remedies are designed as well as how they are implemented. Ex-post assessments of merger remedies allow competition authorities to look retrospectively at previous merger remedy decisions to review whether the remedy proceeded as expected or if things could have gone better. This enables competition authorities to refine and improve their practices and be confident in their decision making going forward.
In December 2023, the OECD Global Forum on Competition considered several aspects of ex-post assessments of merger remedies, including reviews that consider the implementation of the remedy as well as those that consider its design. It also discussed the need for them in competition authorities’ toolkits, and how best to implement them effectively according to the resources available.
This page contains all session information and materials.